SCHEMBL6701885

SCHEMBL6701885

Fc1ccc(-c2ccc(OCc3ccc(C4CCCCC4)cc3)c(CBr)c2)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 4/20 0.46
APP P05067 1/20 0.41
SLC6A4 P31645 5/20 0.40
SLC6A2 P23975 4/20 0.40
SLC6A3 Q01959 4/20 0.40
HTR1A P08908 3/20 0.40
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 1/20 0.39
FEN1 P39748 2/20 0.39
F10 P00742 1/20 0.38
MEN1 O00255 1/20 0.36
PKM P14618 1/20 0.36
KMT2A Q03164 1/20 0.36
PTGDR2 Q9Y5Y4 2/20 0.35
PTGDR Q13258 1/20 0.35
HRH3 Q9Y5N1 1/20 0.34
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6700407 0.90 FFAR4 (0.50) FFAR4APPSLC6A4SLC6A2SLC6A3
SCHEMBL6697870 0.89 FFAR4 (0.47) FFAR4APPSLC6A4SLC6A2SLC6A3
SCHEMBL6699132 0.88 FFAR4 (0.44) FFAR4APPSLC6A4SLC6A2SLC6A3
SCHEMBL6703184 0.81 FFAR4 (0.46) FFAR4APPCYP3A4CYP2C9FEN1
SCHEMBL7069408 0.78 FFAR4 (0.44) FFAR4APPSLC6A4SLC6A2SLC6A3
SCHEMBL6696278 0.77 FFAR4 (0.43) FFAR4APPCYP3A4CYP2C9FEN1
SCHEMBL6700856 0.75 FFAR4 (0.51) FFAR4FEN1
SCHEMBL2889244 0.73 FFAR4 (0.46) FFAR4SLC6A4SLC6A2SLC6A3HTR1A
SCHEMBL14774657 0.72 SMN1; SMN2 (0.49) FFAR4APPSLC6A4SLC6A2SLC6A3
SCHEMBL2889457 0.70 SLC6A2 (0.43) FFAR4SLC6A4SLC6A2SLC6A3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040176446-A1 Substituted amino dicarboxylic acid derivatives BAYER AKTIENGESELLSCHAFT (DE) 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176446-A1 Substituted amino dicarboxylic acid derivatives BCAT2, BCAT1, AADAT FFAR4 749/4885APP 2469/4885SLC6A4 884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.